IndraLab

Statements



reach
": Psychiatric medications vulnerable mild CYP2D6 metabolism inhibition by chloroquine or hydroxychloroquine."
| PMC

eidos
"HCQ may also inhibit CYP2D6 , interacting with a variety of different COVID-19 and non-COVID-19 medications ."
| PMC

eidos
"In fact , chloroquine and hydroxychloroquine inhibit CYP2D6 , which metabolizes several antipsychotics , antidepressants , and antihistamines , while ritonavir inhibits CYP3A4 , actively involved in the metabolism of some macrolides , azole antifungals , antidepressants , and antihistamines ."
| PMC

reach
"The ability of CQ and HCQ to inhibit CYP2D6 might reduce the analgesic efficacy of opioids which are metabolised by CYP2D6 [123, 124]."

eidos
"25 Last , both HCQ and chloroquine inhibit CYP2D6 , which may increase beta-blocker exposure and risk of bradycardia , PR interval prolongation , and AVN blockade ."

reach
"Moreover, chloroquine and hydroxychloroquine are mild inhibitors of CYP2D6, and have potential interactions with numerous psychotropic medications.Tocilizumab’s neuropsychiatric effects have not been widely studied in the context of COVID-19 treatment."
| PMC

reach
"22, 43 Hydroxychloroquine A moderate inhibitor of CYP2D6 and P-gp and caution may be required when co-administering comedications metabolized or transported by these pathways with a narrow therapeutic index."

reach
"Furthermore, our findings show that HCQ and its metabolites are inhibitors of CYP2D6, which likely explains the previously observed interaction between HCQ and metoprolol."

reach
"Both CQ and HCQ inhibit CYP2D6 activity through competitive mechanisms."

eidos
"HCQ appears to inhibit CYP2D6 and can affect the levels of psychotropic medications dependent on CYP2D6 for their metabolism ."

reach
"HCQ appears to inhibit CYP2D6 and can affect the levels of psychotropic medications dependent on CYP2D6 for their metabolism."

reach
"Both CQ and HCQ inhibit CYP2D6 activity through competitive mechanisms."

reach
"Hydroxychloroquine and chloroquine inhibit CYP2D6 and may increase plasma concentration of metoprolol 48; a similar effect may be observed in carvedilol but has never been studied.Carvedilol is a nonselective beta blocker."

eidos
"18 Chloroquine and hydroxychloroquine also inhibit CYP2D6 , which may increase beta-blocker exposure and risk of bradycardia , PR interval prolongation , and atrioventricular block ."

reach
"Hydroxychloroquine, by inhibiting the CYP2D6, leads to an increase in the serum concentration of beta-blockers."

eidos
"Combined with the fact that HCQ and ritonavir directly inhibit CYP2D6 and CYP3A4 , respectively , there is a potential for QT prolongation culminating in torsades de pointes ( 102 ) ."
| PMC

reach
"[XREF_BIBR XREF_BIBR] Chloroquine and hydroxychloroquine are inhibitors of CYP2D6."

reach
"With increased use of these medications, physicians need to become knowledgeable of these drugs' neuropsychiatric side effects and interactions with psychiatric medications.Methods: Literature review was performed in PubMed from 1950-2020 regarding psychiatric topics and targeted pharmacological properties of chloroquine and hydroxychloroquine.Review: First, chloroquine and hydroxychloroquine may mildly inhibit CYP2D6 metabolism of psychiatric medications, and psychiatric medications that interfere with CYP2D6 or CYP3A4 activity could alter chloroquine and hydroxychloroquine levels."
| PMC

reach
"Hydroxychloroquine and chloroquine inhibit CYP2D6 and may increase plasma concentration of metoprolol 48; a similar effect may be observed in carvedilol but has never been studied."

eidos
"Antirheumatic chloroquine , and hydroxychloroquine , inhibit CYP2D6 , thus requiring adjusting galantamine and donepezil [ 165 ] ."

reach
"Antirheumatic chloroquine, and hydroxychloroquine, inhibit CYP2D6, thus requiring adjusting galantamine and donepezil [165]."

reach
"REVIEW: First, chloroquine and hydroxychloroquine may mildly inhibit CYP2D6 metabolism of psychiatric medications, and psychiatric medications that interfere with CYP2D6 or CYP3A4 activity could alter chloroquine and hydroxychloroquine levels."
| PMC

reach
"18 Chloroquine and hydroxychloroquine also inhibit CYP2D6, which may increase beta-blocker exposure and risk of bradycardia, PR interval prolongation, and atrioventricular block."

reach
"Hydroxychloroquine is metabolized by CYP2D6, CYP3A4, and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A in vitro."

eidos
"Both CQ and HCQ were reported to inhibit CYP2D6 activity [ 58 ] ."

reach
"[XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR] Ritonavir as well as hydroxychloroquine increases the effects of tetrabenazine by inhibiting hepatic enzyme CYP2D6 metabolism."

eidos
"Hydroxychloroquine is metabolized by CYP2D6 , CYP3A4 , and CYP2C8 , and inhibits CYP2D6 , while its metabolites also inhibit CYP3A in vitro ."

reach
"Hydroxychloroquine is a weak inhibitor of CYP2D6 and of the P-gp efflux protein, requiring intensified monitoring when used concomitantly with narrow-window drugs having this metabolic pathway: gefitinib, tamoxifen (Table 2C) ."
| PMC

reach
"Furthermore, CQ and HCQ can inhibit CYP2D6 activity thus suppressing the metabolism of their own and other drugs metabolised by the enzyme."

No evidence text available